Get the content you want anytime you want.
REGISTER NOW | SIGN IN
ARTICLE

Contagion® Welcomes Jason Gallagher, Pharm.D, as Editor in Chief

NOV 01, 2017
Jason Gallagher, Pharm.D., FCCP, FIDSA, BCPS
(CRANBURY, N.J. – November 1, 2017) – Contagion®, the nation’s leading digital and print publication that provides infectious disease practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment and prevention of infectious diseases, has appointed Jason Gallagher, Pharm.D., FCCP, FIDSA, BCPS, as its editor in chief.

Dr. Gallagher hails from the School of Pharmacy at Temple University in Pennsylvania where he serves as the director of the residency program and clinical professor and clinical pharmacy specialist in infectious disease.
           
Throughout his esteemed career, Dr. Gallagher has been responsible for numerous publications, abstracts and book chapters. He has been the president of the Society of Infectious Diseases Pharmacists and has had leadership positions in other societies. Dr. Gallagher is an author of Antibiotics Simplified, which is it its fourth edition, and currently, serves on the Infectious Diseases Specialty Council of the Board of Pharmacy Specialties. His research interests focus on pharmacotherapy of resistant infections, antimicrobial clinical pharmacodynamics, and antibiotic stewardship.
           
“I am excited to accept this role with Contagion® and am looking forward to working to further this new publication into a leading position among infectious diseases publications, growing its utility to practitioners and enhancing its visibility in the medical community,” said Dr. Gallagher about his recent appointment.
           
As editor in chief, Dr. Gallagher will work closely with Contagion®’s editorial team to deliver high-quality and relevant information about recent medical developments and research in infectious diseases. Additionally, Dr. Gallagher will offer exclusive insights about emerging trends in the infectious disease community.
           
“We are honored to be joined by Dr. Gallagher whose extensive background in the field of infectious diseases will offer unique insight to our publication,” said Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, Inc., parent company of Contagion®. “Through our joint efforts, we aim to deliver unparalleled infectious disease content to our readers.”
           
For more information on the Contagion® and its editorial advisory board, please visit www.contagionlive.com/about-us.
 
About Contagion®
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through its website, quarterly journal, email newsletters, social media outlets and Outbreak Monitor, it provides practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment and prevention of infectious diseases. The mission of Contagion® is to assure that the health care community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
           
Contagion® Media Contacts:
Theresa Burek
609-716-7777 ext. 811
tburek@mjhassoc.com

Surabhi Verma
609-716-7777 ext. 851
sverma@mjhassoc.com

FEATURED
Big advances in treatment can